Published October 3, 2018
Webinar October 17
Join our free online webinar on October 17: Introduction to Investtech by Sales Manager Jan Marius van Leeuwen and Analyst Kiran Shroff.
I like price formations, especially Rectangle. They are quick to assess, easy to understand and most importantly one cannot miss it even if they are seen without support and resistance lines. So easy it is. And above all, once they break out either way, chances are high that they follow the same direction. Investtech has done extensive research on this formation in the Scandinavian markets for a given time period. We came out with some impressive numbers that show the Rectangle formation has produced better return than the index. More can be read about this research and its results here.
Investors over time have bought Walt Disney shares steadily at higher prices and the stock is in a rising trend channel in the medium term chart. The stock on Tuesday closed at its highest level, just breaking out from the ceiling of the rectangle since the begynning of 2016. This signals increasing optimism among investors and indicates continued rise in price.
The price formation gives a target of 134-135 dollars and in case of a reaction back there is support between 113-109 dollars. This give a favourable risk-reward ratio.
To add to this interesting case, the volume balance indicator has been very positive and momentum in the stock is rising. Hence the stock is overall assessed as technically positive for the medium to long term.
Investtech's outlook (one to six weeks): Positive
After being inside an almost horizontal trend for over an year, Vertex Pharmaceutica has given a breakout from two rectangle formations at the same time. The formation gives a price target of a little under 230 dollars. In case of a reaction downwards, there is support around 177.
Positive volume balance shows that volume is higher on days with rising prices than days with falling prices. This indicates increasing optimism among investors. The RSI curve shows a rising trend, which could be an early signal for the start of a rising trend for the price as well.
Investtech's outlook (one to six weeks): Positive
Bank of America Corp is in a rising trend channel in both the medium and long term chart. Interesting to see that the stock has broken down from a rectangle formation and closed very close to the uptrend line in Tuesday's trade. Also it is testing its earlier support level around 29.20. A break and close below this level can initiate fresh selling in Bank Of America stocks and it can tumble down to 27.70 dollars or lower.
Volume has previously been low at price tops and high at price bottoms. This weakens the rising trend and could be an early signal for a coming trend break. So keep an eye on this stock.
There is resistance around 30.13 and 30.40.
Investtech's outlook (one to six weeks): Watch
Note: These instruments are traded in currency based on the exchange or country they are listed on.
The analyses are based on closing price as per October 2, 2018.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.